`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`CERTIFICATE OF CORRECTION
`
`
`
`PRINTER'STRIMLINE
`
`PATENT NO.
`
`:
`
`8,865,190
`
`APPLICATION NO.:
`
`14/231 ,971
`
`ISSUE DATE
`
`INVENTOR(S)
`
`:
`
`:
`
`October 21, 2014
`
`John R. PLACH EI'KA
`
`Page 1 of 1
`
`Ther., 32(3):4l4-424, 2010.--.
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as
`shown below:
`
`In title page, item (56) References Cited - US. Patent Documents, delete the 54th
`reference on page 2 "6,126,816 A 10/2000
`Ruiz, Jr.".
`
`In title page, item (56) References Cited - Foreign Patent Documents, insert --JP
`2005-145894
`6/2005--.
`
`In title page, item (5 6) References Cited - Other Publications, insert --Goldstein et al.,
`“PA32540 (Enteric-coated aspirin 325 mg + immediate-release omeprazole 40mg) is
`associated with significantly fewer gastric ulcers and significantly less endoscopic
`erosive esophagitis than enteric-coated aspirin (EC-ASA) alone: Results of two phase 3
`studies,” The American Journal ofGastroenterology, vol. 107, Suppl. 1, pp. 853-854,
`2012.--.
`
`In title page, item (56) References Cited - Other Publications, insert --Miner et al.,
`“Clinical trial: evaluation of gastric acid suppression with three doses of immediate-
`release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole
`magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg:
`a randomized, open-label, Phase I study in healthy volunteers,” Aliment. Pharmacol.
`
`L
`
`MAILING ADDRESS OF SENDER:
`Parker Highlander PLLC
`1120 8. Capital of Texas Highway, Building One, Suite 200
`Austin, Texas 78746
`
`{00187540}
`
`